Paroxysmal Nocturnal Hemoglobinuria Treatment Market Growth, Trends Report 2035
The global paroxysmal nocturnal hemoglobinuria treatment market was valued at USD 5 billion in 2025 and is expected to reach USD 13.94 billion by 2035. The market is projected to register a CAGR of approximately 10.8% during the forecast period from 2026 to 2035. Market expansion is being fueled by increasing diagnosis rates of rare blood disorders, growing adoption of targeted therapies, and continuous advancements in complement inhibition treatments that improve patient outcomes and quality of life.
Request Sample @ https://www.researchnester.com/sample-request-6655
